NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/23/2023
Back to search
Official data from USPTO
OBSTO PEPTIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
OBSTO PEPTIDE
ST13
US500000097287841Class
5
Filing
97287841
Registration
7063759
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/23/2023
Trademark type
Word
Nice classes
5
Filing date
02/28/2022
Registration date
05/23/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/23/2023
Last transaction
05/23/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/02/2022
First use in commerce
02/02/2022
Drawing code
4
Owner type
03
Owner location
Pleasant Grove, UT, KY
Examiner
MCMORROW, RONALD
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
JUUVA ENTERPRISES, INC.
Representatives
Elizabeth Oliner OLINER LAW
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary and nutritional supplements; Dietary supplements also containing amino acids; Natural dietary supplements; Transdermal patches featuring a formula consisting of natural ingredients to aid in weight management and provide other specific and general health benefits
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/23/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/21/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/20/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/04/2023
IUAF
USE AMENDMENT FILED
03/17/2023
EISU
TEAS STATEMENT OF USE RECEIVED
03/17/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/29/2022
PUBO
PUBLISHED FOR OPPOSITION
11/29/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/09/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/26/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
10/26/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/26/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
10/26/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/26/2022
DOCK
ASSIGNED TO EXAMINER
10/22/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/03/2022
NWAP
NEW APPLICATION ENTERED
03/03/2022
Continuous trademark protection
Get notified about every new filing that threatens OBSTO PEPTIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.